Federal health agencies on Tuesday called for a pause in the use of Johnson & Johnson’s coronavirus shot as they examine a rare blood-clotting disorder that emerged in six recipients.
Every state, the District of Columbia and Puerto Rico halted their rollout of the Johnson & Johnson vaccine almost immediately. The same went for the U.S. military, federally run vaccination sites, and CVS, Walgreens, and other stores.
Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world.
Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.
For more information on today’s episode, visit nytimes.com/thedaily. Transcripts of each episode will be made available by the next workday.
Connect with listeners
Podcasters use the RadioPublic listener relationship platform to build lasting connections with fansYes, let's begin connecting
Find new listeners
Understand your audience
Engage your fanbase